EC5026

· EicOsis Human Health Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for EC5026, covering 2021-06-30 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study) [Phase 1, Phase 2]